James Allison, PhD - Immune Checkpoint Blockade in Cancer Therapy (2020)

Поделиться
HTML-код
  • Опубликовано: 23 ноя 2020
  • The 7th International Symposium on Focused Ultrasound was held virtually November 9-13, 2020. This biennial event is hosted by the Focused Ultrasound Foundation. For more information about focused ultrasound technology and the Foundation, visit www.fusfoundation.org.

Комментарии • 6

  • @georgereese2066
    @georgereese2066 3 года назад +1

    the clarity of the lecture was outstanding!!! even if you are a person outside the scope of medicine you WILL o understand how the checkpoint inhibitors work!!! Only a Superior Talent like Dr Allison is able to translate a complicated concept with such Amazing Clarity Thank You Dr Allison. dr Katherine Reese

  • @billytheweasel
    @billytheweasel 2 года назад

    It's unnerving that JAMA published a study, "Cost-effectiveness of Nivolumab-Ipilimumab Combination Therapy...Non-small Cell Lung Cancer".
    It said combo therapy is not cost effective compared to chemo for quality of life years in dollar terms.
    I wish more doctors were like scientists, and that health insurance companies were more in the health business than insurance business.

  • @mpoharper
    @mpoharper Год назад

    Not all melanoma is like cutaneous melanoma. Mucosal melanomas are really cold tumors.

  • @hello15848
    @hello15848 3 года назад +1

    Where was this information last year when my sister died of cervical cancer? Why are cancer centers not using this treatment? 15 years she suffered with chemo and this treatment actually works! Shameful.

    • @elon2159
      @elon2159 2 года назад

      All these new treatments fall under an umbrella term called cancer immunotherapy it's a whole new field of cancer treatment, it's only been around since 2015 so there are plenty of doctors who essentially are ignorant.

    • @mpoharper
      @mpoharper Год назад +1

      we are at the mercy of available trials currently. Many disallow low responder cancer types from current trials. Drug companies want big wins. I am so sorry for your loss.